M&T Bank
TOVX icon

M&T Bank’s Theriva Biologics TOVX Stock Holding History

M&T Bank’s Portfolio TOVX Stock Details TOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4
Closed -$66K – 1770
2016
Q2 		$66K Hold
4
– – ﹤0.01% 1546
2016
Q1 		$86K Hold
4
– – ﹤0.01% 1571
2015
Q4 		$83K Hold
4
– – ﹤0.01% 1590
2015
Q3 		$83K Hold
4
– – ﹤0.01% 1628
2015
Q2 		$104K Hold
4
– – ﹤0.01% 1874
2015
Q1 		$80K Hold
4
– – ﹤0.01% 1863
2014
Q4 		$53K Hold
4
– – ﹤0.01% 1921
2014
Q3 		$65K Buy
+4
New +$65K ﹤0.01% 2059

Other funds holding TOVX

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

M&T Bank's TOVX Position: Q3 2016 in Review

M&T Bank sold out of Theriva Biologics (TOVX) in Q3 2016, closing a stake of 4 shares — an estimated $66K sold.

M&T Bank first reported a position in TOVX in Q3 2014 and held it in 8 quarters. The position peaked at $104K in Q2 2015. 60 funds tracked by Wall St. Rank hold TOVX as of Q3 2016.

  • M&T Bank reported no remaining Theriva Biologics position as of Q3 2016 after selling out during the quarter.
  • M&T Bank sold 4 Theriva Biologics shares in Q3 2016, an estimated $66K.
  • M&T Bank first reported a position in Theriva Biologics in Q3 2014 and held it in 8 quarters.
  • M&T Bank's Theriva Biologics position peaked at $104K in Q2 2015.
  • 60 funds tracked by Wall St. Rank held Theriva Biologics as of Q3 2016.

Based on M&T Bank's 13F filing for Q3 2016, filed 4 Nov 2016.